Joseph Edward Tucker

CIK: 0001883914

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ENVB

Enveric Biosciences, Inc.

DirectorOfficer

LABT

Lakewood-Amedex Biotherapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

ENVB
Enveric Biosciences, Inc.
Jun 1, 2026
Award(A)
Direct
201.1K shares-
LABT
Lakewood-Amedex Biotherapeutics Inc.
Apr 24, 2026
Award(A)
Warrant to acquire Common Stock
Direct
33.8K shares-
ENVB
Enveric Biosciences, Inc.
Dec 23, 2025
Award(A)
Direct
60.3K shares-
ENVB
Enveric Biosciences, Inc.
May 8, 2025
Award(A)
Direct
98.9K shares-
ENVB
Enveric Biosciences, Inc.
Oct 9, 2024
Award(A)
Direct
161.6K shares-

		Type	Shares	Price		Ownership
Jun 1, 2026	ENVB Enveric Biosciences, Inc.	Award(A)	201,124	-	$0	Direct
Apr 24, 2026	LABT Lakewood-Amedex Biotherapeutics Inc.	Award(A) Warrant to acquire Common Stock	33,784	-	-	Direct
Dec 23, 2025	ENVB Enveric Biosciences, Inc.	Award(A)	60,296	-	-	Direct
May 8, 2025	ENVB Enveric Biosciences, Inc.	Award(A)	98,866	-	-	Direct
Oct 9, 2024	ENVB Enveric Biosciences, Inc.	Award(A)	161,633	-	$0	Direct

1-5 of 5 transactions

About Tucker Joseph Edward

Tucker Joseph Edward (SEC CIK 0001883914) files insider reports with the SEC as Chief Executive Officer of Enveric Biosciences, Inc. (ENVB) and Director of Lakewood-Amedex Biotherapeutics Inc. (LABT).

Signal8 holds 6 ownership filings by Tucker Joseph Edward (1 Form 3, 5 Form 4), filed between Oct 11, 2024 and Jun 3, 2026. Those filings report 5 transactions, from Oct 9, 2024 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Tucker Joseph Edward's filings is in CAMBRIDGE, MA.

Recent filings by Tucker Joseph Edward

Jun 1, 2026: Grant or award of ENVB shares (Form 4, code A).
Apr 24, 2026: Grant or award of LABT derivative securities (Form 4, code A).
Dec 23, 2025: Grant or award of ENVB shares (Form 4, code A).
May 8, 2025: Grant or award of ENVB shares (Form 4, code A).
Oct 9, 2024: Grant or award of ENVB shares (Form 4, code A).

Other insiders filing for Enveric Biosciences, Inc. (ENVB)

Coveney Kevin Michael, Chief Financial Officer
PASQUALONE FRANK, Director
WEBB MICHAEL D, Director
Schabacker Marcus, Director
Kegler George A., Director
DeWitt Sheila, Director

How to read Form 4 transaction codes